{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:24:59Z","timestamp":1794273899489,"version":"4.9.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023B1515020109"],"award-info":[{"award-number":["2023B1515020109"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070626"],"award-info":[{"award-number":["32070626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32570663"],"award-info":[{"award-number":["32570663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32460138"],"award-info":[{"award-number":["32460138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32560140"],"award-info":[{"award-number":["32560140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470609"],"award-info":[{"award-number":["32470609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171262"],"award-info":[{"award-number":["32171262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AT070436"],"award-info":[{"award-number":["202401AT070436"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AT070019"],"award-info":[{"award-number":["202401AT070019"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401BF070001-013"],"award-info":[{"award-number":["202401BF070001-013"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202301AT070083"],"award-info":[{"award-number":["202301AT070083"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202201BF070001-015"],"award-info":[{"award-number":["202201BF070001-015"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202501AS070057"],"award-info":[{"award-number":["202501AS070057"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFC3409700"],"award-info":[{"award-number":["2025YFC3409700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102933","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:04:35Z","timestamp":1776384275000},"page":"102933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["ClinASO: An open-source platform for rapid drug discovery of gapmer antisense oligonucleotides"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-2846","authenticated-orcid":false,"given":"Shunkai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezi","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-0271","authenticated-orcid":false,"given":"Yunkun","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102933_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide","volume":"75","author":"Stephenson","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102933_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102933_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102933_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/nar\/19.5.1113","article-title":"Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism","volume":"19","author":"Boiziau","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib5","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of oligonucleotide-based therapeutics: challenges and opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102933_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40259-024-00644-7","article-title":"Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases","volume":"38","author":"Chen","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtn.2026.102933_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186116","article-title":"The expanding application of antisense oligonucleotides to neurodegenerative diseases","volume":"134","author":"Sumner","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102933_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102933_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101416","article-title":"Antisense oligonucleotides for inherited retinal diseases: a comprehensive review","volume":"106","author":"Banadaki","year":"2025","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/13543784.2020.1804853","article-title":"Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases","volume":"29","author":"Xue","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.omtn.2026.102933_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf778","article-title":"Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations","volume":"53","author":"Christensen","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40259-024-00665-2","article-title":"Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs","volume":"38","author":"Sang","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtn.2026.102933_bib14","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1016\/S0021-9258(19)85268-7","article-title":"Evaluation of 2\u2018-modified oligonucleotides containing 2\u2018-deoxy gaps as antisense inhibitors of gene expression","volume":"268","author":"Monia","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102933_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.102933_bib16","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102933_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2026.102933_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/nar\/gky1260","article-title":"Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay","volume":"47","author":"Gaus","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib19","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1093\/nar\/gkae284","article-title":"Short 2'-O-methyl\/LNA oligomers as highly-selective inhibitors of miRNA production in vitro and in vivo","volume":"52","author":"Koralewska","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib20","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1093\/nar\/25.22.4429","article-title":"The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes","volume":"25","author":"Freier","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib21","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1021\/acs.jmedchem.6b00551","article-title":"The Medicinal Chemistry of Therapeutic Oligonucleotides","volume":"59","author":"Wan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.omtn.2026.102933_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","article-title":"Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index","volume":"37","author":"Shen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102933_bib23","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2026.102933_bib24","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1093\/nar\/gku531","article-title":"Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice","volume":"42","author":"Prakash","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","article-title":"Carbohydrate-specific receptors of the liver","volume":"51","author":"Ashwell","year":"1982","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omtn.2026.102933_bib26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.molcel.2019.12.029","article-title":"Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination","volume":"77","author":"Lai","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.102933_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.72","article-title":"A Kinetic Model Explains Why Shorter and Less Affine Enzyme-recruiting Oligonucleotides Can Be More Potent","volume":"3","author":"Pedersen","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102933_bib28","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/nar\/28.6.1340","article-title":"Effects of RNA secondary structure on cellular antisense activity","volume":"28","author":"Vickers","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib29","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gky397","article-title":"Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice","volume":"46","author":"Hagedorn","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102351","article-title":"Mechanistic insights into ASO-RNA complexation: Advancing antisense oligonucleotide design strategies","volume":"35","author":"H\u00f6rberg","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102933_bib31","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1093\/nar\/gkx1073","article-title":"RNase H sequence preferences influence antisense oligonucleotide efficiency","volume":"45","author":"Kielpinski","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12844-z","article-title":"Influence of mismatched and bulged nucleotides on SNP-preferential RNase H cleavage of RNA-antisense gapmer heteroduplexes","volume":"7","author":"Magner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102933_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40291-021-00573-z","article-title":"Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension","volume":"26","author":"Yasuhara","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omtn.2026.102933_bib34","article-title":"Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients","volume":"9","author":"Glorioso","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102933_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41467-021-27899-w","article-title":"Modeling uniquely human gene regulatory function via targeted humanization of the mouse genome","volume":"13","author":"Dutrow","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102933_bib36","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.csbj.2025.09.022","article-title":"ASOG: AntiSense Oligonucleotide Generator","volume":"27","author":"Kimi","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.omtn.2026.102933_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238753","article-title":"PFRED: A computational platform for siRNA and antisense oligonucleotides design","volume":"16","author":"Sciabola","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102933_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/bioinformatics\/15.2.172","article-title":"TargetFinder: searching annotated sequence databases for target genes of transcription factors","volume":"15","author":"Lavorgna","year":"1999","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102933_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtn.2026.102933_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-7188-6-26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithm Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102933_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102933_bib43","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1074\/jbc.RA119.008094","article-title":"Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice","volume":"294","author":"Lebeau","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102933_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102933_bib45","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102933_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib47","article-title":"Inclisiran: a new generation of lipid-lowering siRNA therapeutic","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102933_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe9117","article-title":"An oral antisense oligonucleotide for PCSK9 inhibition","volume":"13","author":"Gennemark","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(22)02466-4","article-title":"Etesian: a phase 2b study of the efficacy, safety and tolerability of azd8233, a pcsk9-targeted antisense oligonucleotide, in patients with dyslipidemia","volume":"79","author":"Koren","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.omtn.2026.102933_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115960","article-title":"Novel ASO therapeutic target designed against hyperlipidemia via PCSK9 knockdown","volume":"170","author":"Yu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.102933_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/352073a0","article-title":"Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein","volume":"352","author":"Sun","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102933_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32893","article-title":"IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling","volume":"7","author":"Yoneyama","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2026.102933_bib54","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s00125-016-4072-7","article-title":"IRS proteins and diabetic complications","volume":"59","author":"Lavin","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.omtn.2026.102933_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.2009.03450.x","article-title":"Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a 'first in man' phase I investigation","volume":"68","author":"Kain","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102933_bib56","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2026.102933_bib57","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2026.102933_bib58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/jpet.108.147496","article-title":"Potent in vivo antiangiogenic effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1","volume":"329","author":"Al-Mahmood","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.omtn.2026.102933_bib60","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.18240\/ijo.2019.09.03","article-title":"Blockade of insulin receptor substrate-1 inhibits biological behavior of choroidal endothelial cells","volume":"12","author":"Qian","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2026.102933_bib59","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.chembiol.2018.01.013","article-title":"SRPKIN-1: A Covalent SRPK1\/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform","volume":"25","author":"Hatcher","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.omtn.2026.102933_bib61","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1167\/iovs.13-11634","article-title":"SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity","volume":"54","author":"Gammons","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2026.102933_bib62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction\u2013Associated Steatotic Liver Disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102933_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI198334","article-title":"The pathogenesis of hepatic steatosis in MASLD: a lipid droplet perspective","volume":"135","author":"Krahmer","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102933_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2026.102933_bib65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11010-024-04975-5","article-title":"ACSL4 accelerates osteosarcoma progression via modulating TGF-\u03b2\/Smad2 signaling pathway","volume":"480","author":"Li","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.omtn.2026.102933_bib66","first-page":"249","article-title":"A platform for personalized ASO therapeutics","volume":"24","author":"Crunkhorn","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102933_bib67","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS","volume":"41","author":"\u00d8stergaard","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102933_bib69","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1093\/nar\/gku142","article-title":"Sequence motifs associated with hepatotoxicity of locked nucleic acid\u2014modified antisense oligonucleotides","volume":"42","author":"Burdick","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102933_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221827","article-title":"Ex Vivo Tools and Models in MASLD Research","volume":"13","author":"Velliou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2026.102933_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102933_bib72","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102933_bib73","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.102933_bib74","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:11:32Z","timestamp":1794273092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126001046"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102933","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ClinASO: An open-source platform for rapid drug discovery of gapmer antisense oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102933"}}